Table 1. Serum VNA-BoNTA levels following Ad/VNA-BoNTA administration via different routes.
Routea | Estimated serum VNA-BoNTA levels (nM)b | Average(nM) | Average(µg/ml) | ||||
Mouse 1 | Mouse 2 | Mouse 3 | Mouse 4 | Mouse 5 | |||
iv | 6000 | 30000 | 50000 | 10000 | 50000 | 29000 | 970 |
ip | 0.015 | 4000 | 4000 | 0.03 | 1000 | 1800 | 60 |
im | ND | 1000 | 1000 | 2000 | 800 | 960 | 32 |
sq | 400 | 100 | 1000 | 200 | 40 | 350 | 12 |
ND- not determined.
Routes by which Ad was administered; iv-intravenous, ip-intraperitoneal, im-intramuscular, sq-subcutaneous.
Serum was collected 4 days post-treatment and VNA levels estimated by dilution ELISA for binding to toxin targets.